Sree Rayalaseema Hi-Strength Hypo share news, announcements and annual reports
NSE: SRHHYPOLTDBSE: 532842Chemicals & PetrochemicalsSmall Cap
Sree Rayalaseema Hi-Strength Hypo Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2007
Last close ₹485.20down ₹13.95 (2.79%)BSE ₹485.60
Share price at the NSE close on 30 Oct 2026. Previous close ₹499.15.
30 Oct: open ₹502.30, high ₹502.30, low ₹483.00
52-week range of traded prices to 30 Oct 2026
₹382.40Low, 30 Mar 2026₹670.00High, 22 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹833 Cr1,584th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 9.05
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹12 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 7.98
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.86
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.62%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹12 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 11.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,06674.6% delivered
Sree Rayalaseema Hi-Strength Hypo share news and announcements
512 announcements, routine notices left out, newest first. Page 9 of 11.
Apr 2015
Mar 2015
Feb 2015
3 Feb · Board meeting
Interalia, to consider and to take on record the un-audited Financial Results fo the quarter/Nine Months period ending December 31, 2014.
Nov 2014
3 Nov · Board meeting
Interalia, to consider and to take on record the Unaudited Financial Results for the second quarter/half year ending September 30, 2014.
Sep 2014
5 Sep · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from September 25, 2014 to September 29, 2014 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on September 29, 2014.5 Sep · Board meeting
Board of Directors of the Company in their meeting held on August 14, 2014 had decided the following; 1. The Company is providing e-voting facility through CDSL platform and voting period begins on September 22, 2014 and ends on September 24, 2014. 2. The Company is providing postal ballot facility to shareholders who do not have access to e-voting facility and duly completed ballot forms should reach the Scrutinizer Mr. M, Nirmal Kumar Reddy not later than September 24, 2014.
Aug 2014
Jul 2014
31 Jul · Board meeting
Intimation regarding date of Board Meeting - Un Audited Financial Results for the First Quarter ending 30.06.2014 - Reg
May 2014
20 May · Board meeting
Inter alia, to consider and to take on record the Audited Financial Results for the year ending March 31, 2014.
Apr 2014
Mar 2014
Feb 2014
14 Feb · Results
Nov 2013
15 Nov · Results
5 Nov · Board meeting
To consider Unaudited Financial Results for quarter/half year ending 30.09.2013.
Sep 2013
30 Sep · Meeting
Aug 2013
2 Aug · Board meeting
Interalia, to consider and to take on record the Un Audited Financial Results for the first quarter ending 30th June, 2013.
Jul 2013
Jun 2013
May 2013
9 May · Board meeting
Inter alia, to consider and to take on record the Audited Financial Results for the year ending March 31, 2013.
Feb 2013
4 Feb · Board meeting
Interalia, to consider and to take on record the Un-Audited Financial Results for the quarter/nine months period ending December 31, 2012.
Jan 2013
Nov 2012
29 Nov · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from December 24, 2012 to December 28, 2012 (both days inclusive) for the purpose of Annual General Meeting. The Annual General Meeting of the members of the Company will be held on December 28, 2012.29 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 28, 2012, inter alia, has decided the following: (1)To allot 7,35,830 convertible share warrants of Rs. 10/- each at a rate of Rs. 55.74 (including premium of Rs 45.74) calculated as per Chapter VII of SEBI (ICDR). Regulations,2009 to M/S Gowri Gopal Hospitals Pvt Ltd, one of the Promoter of the Company under Preferential issue subject to members approval in the ensuing Annual General Meeting to be held on December 28, 2012. These share warrants are to be converted into equity shares within 18 months from the date of allotment of warrants.19 Nov · Board meeting
To consider the allotment of Equity shares under preferential issue to one of the promoters of the Company and fixation of price of the same.15 Nov · Business
Board of Directors of the Company in the meeting held on November 14, 2012 have allotted 24,86,028 Equity shares of Rs. 10/- each of the Company to the shareholders of Transferor Companies Viz., SRHHL Industries Ltd (Transferor Co.,1) in the ratio of 23:200 and T G V Pharma Pvt Ltd (Transferor Co.,2) in the ratio of 790:100 in pursuance to Scheme of Arrangement duly approved by Hon'ble High Court of Andhra Pradesh vide its Order dated August 31, 2012.6 Nov · Board meeting
Interalia, to consider and to take on record the Un Audited Financial Results for the quarter ending September 30, 2012.
Oct 2012
22 Oct · Results
11 Oct · Board meeting
Inter alia, to consider and to take on record the merged Audited Financial Results: for the year ending March 31, 2012 and fixation of Record Date for allotment of new shares to the shareholders of transferor Companies Viz., SRHHL Industries Ltd. and T G V Pharma Pvt. Ltd. in pursuance to Scheme of Arrangement duly approved by Hon'ble High Court of Andhra Pradesh vide its Order dated August 31, 2012.9 Oct · Meeting
In view of pending approval of Scheme of Arrangement before Hon'ble High Court of Andhra Pradesh, the Company had requested Registrar of Companies (ROC) to extend time up to December 31, 2012 for holding Annual General Meeting for the year 2011-12. The ROC vide its letter dated August 21, 2012 had extended three months time for holding AGM. Further, the Company has informed the Exchange that Hon'ble High Court of Andhra Pradesh vide its Order dated August 31, 2012 approved the Scheme of Arrangement. The Company is in the process of preparing consolidated Audited Annual Accounts for the year 2011-12 and the date of Board Meeting will be intimated shortly.